Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of BLISS GVS PHARMA. For more details, see the BLISS GVS PHARMA quarterly results and BLISS GVS PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.3 |
No. of shares | m | 104.69 |
1 Week | % | 2.1 |
1 Month | % | 8.2 |
1 Year | % | 48.9 |
52 week H/L | Rs | 149.0/71.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BLISS GVS PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 225 | 184 | 224 | 133 | 91 | |
Low | Rs | 125 | 74 | 86 | 66 | 67 | |
Sales per share (Unadj.) | Rs | 87.1 | 66.8 | 56.0 | 72.1 | 72.2 | |
Earnings per share (Unadj.) | Rs | 12.3 | 9.2 | 7.2 | 2.2 | 7.4 | |
Diluted earnings per share | Rs | 12.1 | 9.1 | 7.1 | 2.2 | 7.3 | |
Cash flow per share (Unadj.) | Rs | 13.1 | 10.5 | 8.8 | 3.9 | 9.2 | |
Dividends per share (Unadj.) | Rs | 1.00 | 0.50 | 0.50 | 0.50 | 0.50 | |
Adj. dividends per share | Rs | 0.99 | 0.49 | 0.49 | 0.50 | 0.50 | |
Avg Dividend yield | % | 0.6 | 0.4 | 0.3 | 0.5 | 0.6 | |
Book value per share (Unadj.) | Rs | 62.6 | 71.3 | 77.4 | 78.0 | 84.0 | |
Adj. book value per share | Rs | 61.7 | 70.3 | 76.3 | 77.3 | 83.6 | |
Shares outstanding (eoy) | m | 103.15 | 103.15 | 103.15 | 103.68 | 104.15 | |
Price / Sales ratio | x | 2.0 | 1.9 | 2.8 | 1.4 | 1.1 | |
Avg P/E ratio | x | 14.2 | 13.9 | 21.6 | 44.6 | 10.8 | |
P/CF ratio (eoy) | x | 13.3 | 12.3 | 17.5 | 25.5 | 8.7 | |
Price / Book Value ratio | x | 2.8 | 1.8 | 2.0 | 1.3 | 0.9 | |
Dividend payout | % | 8.1 | 5.4 | 7.0 | 22.4 | 6.8 | |
Avg Mkt Cap | Rs m | 18,035 | 13,283 | 15,988 | 10,324 | 8,262 | |
Total wages/salary | Rs m | 423 | 537 | 681 | 761 | 862 |
BLISS GVS PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 8,986 | 6,893 | 5,772 | 7,475 | 7,516 | |
Other income | Rs m | 376 | 392 | 220 | 315 | 178 | |
Total revenues | Rs m | 9,362 | 7,285 | 5,992 | 7,789 | 7,694 | |
Gross profit | Rs m | 1,576 | 1,099 | 1,066 | 447 | 1,173 | |
Depreciation | Rs m | 89 | 126 | 172 | 173 | 187 | |
Interest | Rs m | 44 | 76 | 72 | 47 | 104 | |
Profit before tax | Rs m | 1,819 | 1,290 | 1,041 | 542 | 1,061 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 553 | 337 | 302 | 310 | 293 | |
Profit after tax | Rs m | 1,267 | 953 | 740 | 231 | 767 | |
Gross profit margin | % | 17.5 | 15.9 | 18.5 | 6.0 | 15.6 | |
Effective tax rate | % | 30.4 | 26.1 | 29.0 | 57.3 | 27.7 | |
Net profit margin | % | 14.1 | 13.8 | 12.8 | 3.1 | 10.2 |
BLISS GVS PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 6,935 | 7,697 | 7,652 | 7,769 | 6,974 | |
Current liabilities | Rs m | 2,070 | 2,305 | 2,036 | 2,331 | 1,933 | |
Net working cap to sales | % | 54.1 | 78.2 | 97.3 | 72.8 | 67.1 | |
Current ratio | x | 3.3 | 3.3 | 3.8 | 3.3 | 3.6 | |
Inventory Days | Days | 8 | 9 | 48 | 14 | 39 | |
Debtors Days | Days | 1,871 | 2,901 | 2,933 | 1,918 | 1,871 | |
Net fixed assets | Rs m | 2,114 | 2,575 | 3,116 | 3,319 | 4,562 | |
Share capital | Rs m | 103 | 103 | 103 | 104 | 104 | |
"Free" reserves | Rs m | 6,357 | 7,253 | 7,881 | 7,984 | 8,646 | |
Net worth | Rs m | 6,460 | 7,356 | 7,984 | 8,088 | 8,750 | |
Long term debt | Rs m | 325 | 372 | 326 | 232 | 407 | |
Total assets | Rs m | 9,049 | 10,272 | 10,768 | 11,087 | 11,535 | |
Interest coverage | x | 42.2 | 18.0 | 15.4 | 12.4 | 11.2 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 0.7 | 0.5 | 0.7 | 0.7 | |
Return on assets | % | 14.5 | 10.0 | 7.5 | 2.5 | 7.6 | |
Return on equity | % | 19.6 | 12.9 | 9.3 | 2.9 | 8.8 | |
Return on capital | % | 27.5 | 17.7 | 13.4 | 7.1 | 12.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 3,845 | 3,813 | 5,791 | 5,618 | |
Fx outflow | Rs m | 0 | 426 | 745 | 953 | 1,225 | |
Net fx | Rs m | 0 | 3,419 | 3,067 | 4,838 | 4,394 |
BLISS GVS PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 400 | 467 | 640 | 1,355 | 343 | |
From Investments | Rs m | -735 | -479 | -470 | -930 | -78 | |
From Financial Activity | Rs m | 168 | -63 | -208 | -237 | -249 | |
Net Cashflow | Rs m | -219 | 3 | -22 | 89 | 30 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: S R Vaidya | COMP SEC: Aditi Bhatt | YEAR OF INC: 1984 | BSE CODE: 506197 | FV (Rs): 1 | DIV YIELD (%): 0.4 |
Read: BLISS GVS PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare BLISS GVS PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded higher on Tuesday following overnight gain on Wall Street.